Top

Published in:

01-10-2005 | Review

Guidelines for the management of osteoporosis: the present and the future

Author: Juliet Compston

Published in: Osteoporosis International | Issue 10/2005

Abstract

Evidence-based guidelines are increasingly used in the management of osteoporosis and have the potential to produce uniformly high standards of clinical care across different sectors of the health service. National guidelines for the prevention and treatment of osteoporosis are now available in a number of countries and, although sharing similarities, also differ in some respects. This review considers the challenges involved in the development and implementation of guidelines and proposes a paradigm for the unification of guidelines in the future.

Sackett DL, Rosenberg WMC, Gary JAM, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn’t. Brit Med J 312:71–72PubMed

Grol R, Dalhuijzen J, Mokkink H, Thomas S, Veld C, Rutten G (1998) Attributes of clinical guidelines that influence use of guidelines in general practice. Brit Med J 317:858–861PubMed

The AGREE collaboration (2001) Appraisal of guidelines for research and evaluation. www.agreecollaboration.org

Gunawardena H, Speden D, Saharia AR, Wickramasuriya R, Javaid MK, Potter J, Compston J (2004) A multi-centre secondary care based national audit of bone prophylaxis in glucocorticoid induced osteoporosis. Osteoporos Int 15 [Suppl 1]:S11

Bone and Tooth Society of Great Britain, National Osteoporosis Society and Royal College of Physicians (1999) Glucocorticoid-induced osteoporosis. Guidelines on prevention and treatment. Royal College of Physicians, London. www.rcplondon.ac.uk

Kanis JA, Johansson H, Oden A et al (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029–1037CrossRefPubMed

Kanis JA, Johnell O, De Laet et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382CrossRefPubMed

Concato J, Shah N, Horwitz RI (2000) Randomised, controlled trials, observational studies and the hierarchy of research designs. New Engl J Med 342:1887–1892CrossRefPubMed

Benson K, Hartz AJ (2000) A comparison of observational studies and randomized controlled trials. New Engl J Med 342:1878–1886CrossRefPubMed

10.

Vandenbroucke JP (2004) When are observational studies as credible as randomised trials? Lancet 363:1728–1731CrossRefPubMed

11.

Concato J, Horwitz RI (2004) Beyond randomised versus observational studies. Lancet 363:1660–1661CrossRefPubMed

12.

Greenhalgh T (1997) Assessing the methodological quality of published papers. Brit Med J 315:305–308PubMed

13.

Cranney A, Tugwell P, Wells G, Guyatt G (2002) Systematic reviews of randomised trials in osteoporosis: Introduction and methodology. Endocr Rev 4:497–507

14.

Dimai HP, Pietschmann P, Resch H, Leb G, Klaushofer K (2002) Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose. Wien Med Wschr 152:596–612PubMed

15.

Brixen K et al (2002) Consensus report on osteoporosis. Ugeskr Laeger [Suppl] 10

16.

National Agency for Accreditation and Evaluation in Health Care (ANAES) (2000) Les indications des measures quantitatives du tissu osseux: actualization. www.anaes.fr

17.

Dachverbandes der deutschsprachigen osteologischen Fachgesellschaften (DVO) (2003) Osteoporose bei Frauen nach der Menopause und im hoheren Lagensalter, Prophylaxe, Diagnose, Therapie—Emfehlungen des Dachverbandes der deutschsprachigen osteologischen Fachgesellschaften (DVO). www.bergmannsheil.de/leitlinien-dvo (for the English version: www.lutherhaus.de/osteo/leitlinien-dvo/pages/english.php)

18.

Longoni P, Pappalepore V, Bianchi ML, Ortolani S, Sacchi G, Tempesta F (2001) Percorsi diagnostici e terapeutici condivisi sull’osteoporosis. Editech Pharma Srl, Milan

19.

El-Hajj Fuleihan G, Baddoura R, Awada H, Okais J, Risk P, McClung M (2002) Lebanese guidelines on osteoporosis assessment and treatment. Lebanese Med J 50:75–125

20.

Osteoporose Tweede herziene richtlijn (2002). www.cbo.nl/product/richtlijnen/folder20021023121843/article20021118165847/pdf/osteoporose [English summary: Pols HA, Wittenberg J (2002) CBO guideline “Osteoporosis” (2nd version). NTVG Ned Tijdschr Geneeskd 146:1359–1363]

21.

Guía de Práctica Clínica de la Sociedad Espanola de Investigaciones Óseas Y Metabolismo Mineral (SEIOMM) (2001) Osteoporosis postmenopáusica. www.seiomm.org

22.

SBU (The Swedish Council onTechnology Assessment in Health Care). No 165: Osteoporos-prevention, diagnostic och behandling

23.

Medical Products Agency. www.mpa.se

24.

Royal College of Physicians. (1999) Osteoporosis. Clinical guidelines on prevention and treatment and Royal College of Physicians and Bone and Tooth Society of Great Britain: Update on pharmacological interventions and an algorithm for management 2000. Royal College of Physicians, London, www.rcplondon.ac.uk

25.

Scottish Intercollegiate Guidelines Network (SIGN) (2002) Guidelines 56. Prevention and management of hip fracture in older people. SIGN, Edinburgh, www.sign.ac.uk

26.

Scottish Intercollegiate Guidelines Network (2003) Management of osteoporosis. www.sign.ac.uk

27.

Brown JP, Josse RJ, the Scientific Advisory Council of the Osteoporosis Society of Canada (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J [Suppl] 167:1–22; www.osteoporosis.ca

28.

The National Osteoporosis Foundation (NOF) (2003) Physician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC

29.

American Association of Clinical Endocrinologists (2003) Medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis. Endo Pract 9:545–564

30.

Nelson HD, Helfand M, Woolf SH, Allen JD (2002) Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:529–541, 526–528; http://www.ahrq.gov/clinic/3rduspstf/osteoporosis/osteorr.htm

31.

International Society for Clinical Densitometry (ISCD) (2004) J Clin Densitometry 7:7–12; http://www.iscd.org/Visitors/official.cfm

32.

North American Menopause Society (NAMS) http://www.menopause.org/aboutmeno/consensus.htm

33.

American College of Rheumatology ad hoc Committee on Glucocorticoid-induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. 2001 update. Arthritis Rheum 44:1496–1503PubMed

34.

International Osteoporosis Foundation (2001) Osteoporosis in the European Community: A call to action. An audit of policy developments since 1998. www.osteofound.org/advocacy_policy/eu_calltoaction_report.html

35.

European Union Osteoporosis Consultation Panel (2003) Osteoporosis in the European Community: Action plan. A report of the European Union Osteoporosis Consultation Panel. www.osteofound.org/advocacy_policy/eu_policy_project.html

36.

Kanis JA, Borgstrom B, De Laet C, Johansson H, Johnell O, Jonsson B et al (2005) Assessment of fracture risk. Osteoporos Int 16:581–589CrossRefPubMed

37.

Compston JE (2004) UK and US guidelines on glucocorticoid-induced osteoporosis: similarities and differences. Curr Rev Rheumatol 6:66–69

38.

Kanis JA, Johnell O, Oden A, De Laet C, Oglesby A, Jönsson (2002) Intervention thresholds for osteoporosis. Bone 31:26–31CrossRefPubMed

39.

Kanis JA, Johnell O, Oden A, De Laet C, Jönsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258CrossRefPubMed

Title: Guidelines for the management of osteoporosis: the present and the future
Author: Juliet Compston
Publication date: 01-10-2005
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 10/2005
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-005-1894-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Guidelines for the management of osteoporosis: the present and the future

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2005

Osteoporotic pelvic fractures in elderly women

A specific haplotype in the 3′ end of estrogen-receptor alpha gene is associated with low bone mineral density in premenopausal women and increased risk of postmenopausal osteoporosis

The effect of a fracture protocol on hospital prescriptions after minimal trauma fractured neck of the femur: a retrospective audit

Anisotropy changes in post-menopausal osteoporosis: characterization by a new index applied to trabecular bone radiographic images

Differences in peak bone mass in women of European and South Asian origin can be explained by differences in body size

Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis